Life Sciences Clinical D&A PEAK Matrix® characteristics

Leaders eClinical Solutions, Medidata Solutions, Saama

⚫ Leaders enjoy the highest brand recall among the biopharma enterprises and are perceived as end-to-end clinical D&A platforms for clinical development

⚫ Leaders focus on enhancing the performance of the existing capabilities, and building new products around Artificial Intelligence (AI), Machine Learning (ML), Low-code/No-code (LCNC), visualization, etc., to address the most demanding clinical use case

⚫ Leaders offer robust data integration capabilities connecting various clinical data sources, secured data storage, and management with robust advanced analytics for insights generation

⚫ Leaders have established a wide partnership network consisting of clinical technology platform providers, consulting partners, hyperscalers, System Integrators (SIs), and Clinical Research Organization (CROs), enabling them to broaden their offerings and increase enterprise mindshare

Major Contenders

Cytel, IQVIA, Lokavant, Merative, Oracle, TCS, ThoughtSphere, Veeva

⚫ Major Contenders have an integrated approach in certain areas of the clinical value chain. They offer best-in-class clinical D&A solutions targeting a particular segment such as data management, analytics, reporting, and dashboarding

⚫ A few Major Contenders are augmenting advanced analytics into the platform and enhancing data management capabilities to enter the Leader's market

⚫ The platforms provided by Major Contenders are not fully scalable for larger studies, which require complex integration and management of clinical data sources

⚫ Major Contenders have a robust partnership with SIs and clinical platform providers but lack partnership for change management and consulting

Aspirants

Adaptive Clinical Systems, Datavant, NextTrial AI

⚫ Aspirants offer a point solution in specific segments of clinical D&A

⚫ Aspirants lack the robust partnership for data acquisition and management, clinical analytics, implementation, and change management

Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2023

Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2023 | eClinical Solutions is positioned as a Leader

Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 20231,2,3

Vision & capability Measures ability to deliver products successfully

1 Assessments for Adaptive Clinical Systems, Datavant, NextTrial AI, Cytel, and IQVIA excludes platform provider inputs and are based on Everest Group’s proprietary Transaction Intelligence (TI) database, platform providers’ public disclosures, and Everest Group’s interactions with clinical D&A platform buyers

2 Merative is a combined assessment of Merative and Zelta platform

3 Assessment for Veeva is based on partial primary inputs (briefing and demo)

Confidentiality: Everest Group takes its confidentiality pledge very seriously. Any information we collect that is contract specific will only be presented back to the industry in an aggregated fashion